A comprehensive view of Drug Delivery/Ingestion. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Children's Hospital Los Angeles collaborates with United Therapeutics on Phase 4 clinical trial to study rapid infusion of Dinutuximab to treat children with high-risk neuroblastoma, a cancer of the nerve cells; study not yet open for recruiting
Published: June 29, 2022 by Contify Life Science News
Bristol Myers Squibb reports mRNA vaccines more effective at developing COVID-19 antibodies in multiple sclerosis patients treated with oral Zeposia ozanimod than non-mRNA vaccines; observation may help in assisting physicians seeking to optimize care
Published: June 29, 2022 by SeeNews Pharmaceuticals
Gilead resubmits application to FDA for approval of long-acting injectable HIV drug lenacapavir after FDA refused authorization in February due to drug’s compatibility with borosilicate glass vial; Gilead now using aluminosilicate glass vial for drug
Published: June 29, 2022 by SeeNews Pharmaceuticals
Novartis reports 78.8% of multiple sclerosis patients given continuous treatment with injectable drug Kesimpta ofatumumab have no relapse, worsening or condition, disease activity after four years of treatment; Kesimpta had sales of US$195M in Q1
Published: June 29, 2022 by SeeNews Pharmaceuticals
Pfizer, Roivant Sciences announce Priovant Therapeutics JV; Priovant focused on developing autoimmune disease therapies including oral brepocitinib, a potential first-in-class dual inhibitor of TYK2 and JAK1to treat multiple severe autoimmune diseases
Published: June 29, 2022 by Business Wire

Ask us about our Logistic & Supply Chain market view

Trending Chart

Interactive chart with headline count